Related Experiment Video
Updated: Aug 8, 2026

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
Published on: March 8, 2012
Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells
A Puri1, D S Dimitrov, H Golding
1Section on Membrane Structure and Function, NCI, NIH, Bethesda, Maryland 20892.
Insights
A novel experimental system using CD4-carrying plasma membrane vesicles (CD4 PMVs) effectively studied human immunodeficiency virus type 1 (HIV-1) envelope interactions. These CD4 PMVs showed potential for HIV-1 inactivation and fusion mechanism studies.
Area of Science:
- Virology
- Cell Biology
- Biochemistry
Background:
- Understanding interactions between the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (gp120-gp41) and its target receptor, CD4, is crucial for developing antiviral strategies.
- Previous methods for studying these interactions have limitations in mimicking the natural cellular environment.
Purpose of the Study:
- To develop and validate a new experimental system, CD4-carrying plasma membrane vesicles (CD4 PMVs), for studying HIV-1 envelope-receptor interactions.
- To assess the potential of CD4 PMVs in HIV-1 inactivation and understanding fusion mechanisms.
Main Methods:
- CD4 PMVs were generated from HeLa cells expressing CD4 via recombinant vaccinia virus infection.
- Fusion of CD4 PMVs with cells expressing HIV-1 gp120-gp41 was monitored using fluorescence video microscopy and lipophilic fluorescent dyes.
- The effect of CD4 PMVs on HIV-1 infectivity and syncytia formation was evaluated.
Main Results:
- CD4 PMVs successfully facilitated the study of HIV-1 envelope-CD4 interactions, with fusion observed within 30 minutes at 37°C.
- Preincubation with CD4 PMVs reduced HIV-1 infectivity by 10-fold.
- CD4 PMVs demonstrated superior inhibition of syncytia formation compared to soluble CD4 (sCD4).
Conclusions:
- CD4 PMVs represent a valuable tool for elucidating the mechanisms of HIV-1 envelope-mediated fusion.
- The developed CD4 PMV system shows significant potential for the inactivation of HIV-1.
Abstract:
To study interactions between the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (gp120-gp41) and the receptor in the target membrane, CD4, a new experimental system utilizing CD4-carrying plasma membrane vesicles (CD4 PMVs) was developed. CD4 PMVs were prepared by hypotonic lysis of HeLa cells expressing CD4 after infection with recombinant vaccinia virus containing the CD4 cDNA. The CD4 PMVs carried up to 680 CD4 molecules per vesicle. Their fusion with cells expressing gp120-gp41 after infection with recombinant vaccinia virus was monitored by fluorescence video microscopy by using lipophilic fluorescent dyes. Fluorescence changes as a result of fusion occurred within 30 min at 37 degrees C, and little fluorescence changes were seen with cells expressing the noncleaved HIV-1 envelope glycoprotein (gp160). The preincubation of CD4 PMVs with HIV-1 reduced its infectivity 10-fold. The CD4 PMVs were more effective in inhibiting syncytia formation than sCD4. These results demonstrate that CD4 PMVs could be used to study the mechanisms of HIV-1 envelope-mediated fusion and have the potential to inactivate HIV-1.
More Related Videos
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Virion Maturation and Assembly

